SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-005565
Filing Date
2014-11-12
Accepted
2014-11-12 07:00:20
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 868372
2 CERTIFICATION ex_311.htm EX-31.1 15059
3 CERTIFICATION ex_312.htm EX-32.1 15114
4 CERTIFICATION ex_32.htm EX-32 7615
5 img001.jpg GRAPHIC 23753
6 img002.jpg GRAPHIC 28880
7 img003.jpg GRAPHIC 19393
8 img004.jpg GRAPHIC 17845
  Complete submission text file 0001354488-14-005565.txt   1862710

Data Files

Seq Description Document Type Size
9 sbfm-20140930.xml EX-101.INS 65844
10 sbfm-20140930.xsd EX-101.SCH 11706
11 sbfm-20140930_cal.xml EX-101.CAL 23999
12 sbfm-20140930_def.xml EX-101.DEF 16297
13 sbfm-20140930_lab.xml EX-101.LAB 90051
14 sbfm-20140930_pre.xml EX-101.PRE 66106
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 141211010
SIC: 8742 Services-Management Consulting Services